Studies on melanoma have highlighted that IDO enzymes, by inducing FOXP3 release in the tumor microenvironment, promote effector T-cell suppression and generation of regulatory T cells (Tregs) [49]. This evidence concerns the gene FOXP3 and neoplasm.